Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis - Wikidata - wikimedia - TriplyDB

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

http://www.wikidata.org/entity/Q24674389

about

Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Self management programme for ankylosing spondylitis Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbidity Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds En Enteropathic arthritis in Brazil: data from the Brazilian Registry of Spondyloarthritis.The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) instrument for Sweden.Patient reported outcomes: looking beyond the label claim.A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD).Development of the US PSORIQoL: a psoriasis-specific measure of quality of life.Spondyloarthritides: evolving therapies Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis.Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial Health status of patients with ankylosing spondylitis: a comparison with the general population.Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic a Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment.Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?Seronegative spondyloarthropathies: to lump or split?Web-based physiotherapy for people with axial spondyloarthritis (WEBPASS) - a study protocol.Adaptation of Chinese and English versions of the Psoriatic Arthritis Quality of Life (PsAQoL) scale for use in Singapore Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis.Greek adaptation and validation of the Ankylosing Spondylitis Quality of Life (ASQoL) measure Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.Improving the psychological evaluation of exercise referral: Psychometric properties of the Exercise Referral Quality of Life Scale.Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritid Are clinical measures influenced by various ethnic origins in Iranian patients with ankylosing spondylitis?A pilot study.Affective temperament profile in ankylosing spondylitis patients using TEMPS-A

P2860

Q21133692-0347BBDD-F404-4D56-8899-237142AF7F82 Q21195369-8CBC49D2-9F9D-406C-8A75-8644811C0873 Q21245615-F762B1F3-F1B4-4CEE-9373-1667CE356CFC Q24186403-E1D379CA-4190-40B7-8397-8E27961AF53C Q24187492-0367C527-36D5-404D-9CA6-A5856BF11B37 Q24201300-E569C5E4-C11C-4954-B144-FC04E557FFE4 Q24203871-7224807C-A5CD-4144-A34F-62B2B82FA10E Q24235846-19A3F342-D287-4C7D-BDCD-6716CC6FCB22 Q24673687-F6527359-4765-49F1-B08A-30A16D584F5E Q26862017-ACB9AAA6-0C0B-47F1-9F88-2B2648B69820 Q30745189-695A6A7B-A2D6-42CC-9205-9E78F67B8F0B Q33916770-D139BF59-3787-4EE0-9885-4CEE9B9798E9 Q34092035-5D06902B-975F-4129-913D-14C8985D873E Q34114747-735B13DB-D8F9-449D-AA19-4D99FB549B71 Q34302550-692EDF3B-3B75-47D3-B666-98D12ADA1B36 Q34424519-D18B16AB-2606-4B17-AE70-A2B0E6E8FB9D Q34613907-15F10521-590B-44C8-9F3D-AD0BD4F61FC4 Q35071645-A5E8D13E-0D5F-4B04-8FB3-9989DFF511CB Q35537104-34177FF9-F9F5-43DC-B955-68A8C8B50604 Q35553676-13B97E4B-60C5-41F9-9F71-174E1A6F9D62 Q35554918-9BE21C90-DE70-4406-8E62-922F5E6DDA04 Q35638281-1479F757-0D0B-49AA-8298-C9515839D9B8 Q35664666-E69F2AB5-9725-4F26-888C-AB26B223C2BD Q35759171-1B4E0FF1-DF32-460E-B3A8-0C0D550E8146 Q35838797-5B352992-1111-4958-93F6-339D86CB735A Q35880376-02CB07C8-1FED-4A33-9555-2FB59CCEEE7C Q35953430-4B792FF2-1B11-46C0-A7DC-B086593FE8C3 Q36040093-39A959E7-57CE-4CAF-99D6-1917ACAA7484 Q36110768-3042D73B-977E-4A33-9586-31753AA5AEEE Q36166729-754E0461-76F8-49DC-A5D3-5807A04BDB43 Q36907291-EC73FE42-C5EA-48BE-AC76-AD853E989585 Q37078444-5A78D58A-31EF-43A8-868A-33ACA39342CB Q37114630-C89FB69A-FB96-4C7E-A36A-1A28C6C540E9 Q37172795-963F7155-96A6-4A3A-9B10-59B2B25C1D56 Q37530561-10939ECC-587B-4533-824B-90CF0D04A5C2 Q37540721-5BB6B175-0845-4010-95B6-DF5120F03B8E Q37612248-B8B6A2A1-CB65-4A98-AFB3-257A940240AD Q37679286-F9DD2D1E-F6C5-4656-A3FF-6324F5123261 Q37711121-F280DCC4-6BF8-4BDD-BC6F-9E66FD3CDBF3 Q37714745-4CD143D2-B258-4A28-B9A2-D3B3ADB8E320

P2860

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

http://www.wikidata.org/entity/Q24674389

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@ast

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@en

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@nl

type

label

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@ast

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@en

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@nl

prefLabel

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@ast

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@en

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@nl

P1433

Q24674389-931797F8-7010-451A-AD47-D0EAFB5BB869

P1476

Q24674389-9CC5CDBC-51F2-4471-9A9F-566A7D9A28CE

P2093

Q24674389-45685317-D3C3-4FEC-8B6F-D25911E8CB73

Q24674389-51832C55-85C4-41A5-9FE1-224116E4D54B

Q24674389-586AD981-F3AE-493C-B0CE-1ABF32999D1B

Q24674389-8E3AA7D6-348A-487D-9534-5FFEE1D43858

Q24674389-B3239493-EADC-457C-95F3-08C4AE6865C2

Q24674389-B53EDC2C-2BA0-4A7F-B105-35B61EEA2EF9

Q24674389-BBCA7C29-70F5-47BF-BFE4-875CF37FF54A

Q24674389-BC601EA1-0386-4BBE-B09A-2FF4A7B331DA

Q24674389-D21B3326-988D-42C5-A784-1A4B3FE3D0F6

Q24674389-F8B447A1-7DF2-48CD-8A16-AB1AF36A0829

P2860

Q24674389-05A94D71-F6DA-4B84-B00E-844BC4C6A443

Q24674389-068CFEC6-9118-41CF-A322-5915FAEDAA72

Q24674389-09B94FDA-61B8-4430-A863-84EEAD7CC458

Q24674389-1C427EFC-CB7A-4913-8A62-B6E52B7C7D62

Q24674389-3670F76B-A200-48FA-8EAA-5ECBD7139A5D

Q24674389-424B3A8B-7110-408F-869A-D5C1CB0A4866

Q24674389-4853DA83-CCCE-4519-8399-CF54539804A2

Q24674389-51461DB1-8ADB-4D92-94AD-8ABA53B2D22F

Q24674389-5DB69D3E-93D1-4F7D-99DD-E7EFDA874378

Q24674389-75725E6B-541A-4325-B7D3-567466846939

P304

Q24674389-667BBE4F-BCAC-4573-8B4A-5C39A7AE1825

P31

Q24674389-FDA23F61-6E44-4044-B2D6-C253D567646C

P3181

Q24674389-629E3721-0C72-45A9-9BD6-404C31818009

P356

Q24674389-E7D3521C-868F-4625-AB23-C671DE624A9E

P407

Q24674389-1B085E09-3882-48E6-9DC2-452B32EA7B33

P433

Q24674389-07F0C675-55BF-41E8-AF9C-A3BBE8E02595

P478

Q24674389-4B3989D7-906B-4AF2-ABEE-CDF57E793265

P5530

Q24674389-BFDEBBE0-7EF3-4F33-B50E-173FA4A720FA

P577

Q24674389-53A75444-3025-4278-A0FA-6D5025556CF5

P5875

Q24674389-7F32D29E-C9B1-452A-89EC-5177A68C7B2C

P6179

Q24674389-451D4E00-D300-47D3-8437-22C5C20ED235

P698

Q24674389-F910C083-3190-472E-83EC-DEA809B79E41

P921

Q24674389-9180FCD5-261D-42E3-8397-3B9D395F551F

P932

Q24674389-9032DB22-1855-4638-8863-8E5FCC1AC908

P3181

P356

P1433

Annals of the Rheumatic Diseases

P1476

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

@en

P2093

Chamberlain MA

http://www.w3.org/2001/XMLSchema#string

Cook SA

http://www.w3.org/2001/XMLSchema#string

Doward LC

http://www.w3.org/2001/XMLSchema#string

Helliwell PS

http://www.w3.org/2001/XMLSchema#string

Kay LJ

http://www.w3.org/2001/XMLSchema#string

McKenna SP

http://www.w3.org/2001/XMLSchema#string

Spoorenberg A

http://www.w3.org/2001/XMLSchema#string

Tennant A

http://www.w3.org/2001/XMLSchema#string

Whalley D

http://www.w3.org/2001/XMLSchema#string

van der Heijde D

http://www.w3.org/2001/XMLSchema#string

P2860

The QLDS: a scale for the measurement of quality of life in depression.

A new measure of quality of life in depression: testing the reliability and construct validity of the QLDS.

The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency.

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

The Nottingham Health Profile: subjective health status and medical consultations.

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

The international development of the RGHQoL: a quality of life measure for recurrent genital herpes.

Using item mean squares to evaluate fit to the Rasch model.

Evaluation of a functional index and an articular index in ankylosing spondylitis.

Cross-cultural development of a quality of life measure for men with erection difficulties.

P304

20-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1592888

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/ARD.62.1.20

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P5530

3668521

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10991602

http://www.w3.org/2001/XMLSchema#string

P6179

1006904651

http://www.w3.org/2001/XMLSchema#string

P698

12480664

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

P932

1754293

http://www.w3.org/2001/XMLSchema#string